Avita Medical

Australian public company

AVH Australian Securities Exchange ISIN AU000000AVH4 SEC CIK 1762303
Follow Avita Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $26.1M +53.1% vs same quarter last year
Net income −$6.2M +52.8% vs same quarter last year
EPS, diluted −$0.20 +56.5% vs same quarter last year
Operating cash flow −$710K +86.4% vs same quarter last year
Revenue by quarter
$18.4M
$18.5M
$18.4M
$17.1M
$17.6M
$19.3M
$21.7M
$26.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$71.6M−$48.6M
FY24$64.3M−$61.8M
FY23$50.1M−$35.4M
FY22$34.4M-
FY21$29.2M-
FY20$14.3M-
FY19$5.5M-
FY18$929K-
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2582.1%−59.4%−67.8%
FY2485.8%−88.1%−96.3%
FY2384.5%−85.1%−70.6%
FY2282.4%−79.9%-
FY2179.6%−90.8%-
FY2079.2%−299.2%-
FY1976.8%−466.4%-
FY1841.2%−1489.9%-
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$32.2M
FY24−$58.1M
FY23−$39.4M
FY22−$19.5M
FY21−$26.8M
FY20−$23.3M
FY19−$20.3M
FY18−$13.3M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Avita Medical
  • Healthcare median
−100%−75%−50%−25%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAvita MedicalHealthcare median
FY25−67.8%−30.6%
FY24−96.3%−47%
FY23−70.6%−58%
FY22-−80.4%
FY21-−71.9%
FY20-−62.2%
FY19-−46.3%
FY18-−49.6%